{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:25:06Z","timestamp":1791725106845,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107942","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:53:13Z","timestamp":1730771593000},"page":"107942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Photochemical Metal-Free synthesis and biological Assessment of isocryptolepine analogues targeting estrogen receptor Alpha in breast cancer cells"],"prefix":"10.1016","volume":"153","author":[{"given":"F.B.","family":"Bogdanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.Yu.","family":"Balakhonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Volkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.V.","family":"Sonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.E.","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.V.","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu.A.","family":"Piven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Scherbakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.Z.","family":"Shirinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bioorg.2024.107942_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.31917\/2402105","article-title":"History of Cancer Hormonotherapy","volume":"24","author":"Abduloeva","year":"2023","journal-title":"Pract. Oncol."},{"key":"10.1016\/j.bioorg.2024.107942_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.ctdb.2016.12.005","article-title":"Estrogen Hormone Biology","volume":"125","author":"Hamilton","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bioorg.2024.107942_b0025","doi-asserted-by":"crossref","unstructured":"P. Miziak, M. Baran, E. Blaszczak, A. Przybyszewska-Podstawka, J. Kalafut, J. Smok-Kalwat, M. Dmoszynska-Graniczka, M. Kielbus, A. Stepulak, Estrogen Receptor Signaling in Breast Cancer, Cancers (Basel) 15(19) (2023) 4689, https:\/\/doi.org\/10.3390\/cancers15194689.","DOI":"10.3390\/cancers15194689"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107942_b0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4184\/asj.2016.10.4.787","article-title":"Selective Estrogen Receptor Modulators","volume":"10","author":"An","year":"2016","journal-title":"Asian Spine J."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41416-023-02158-5","article-title":"Tamoxifen evolution","volume":"128","author":"Howell","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/ERC-20-0335","article-title":"50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?","volume":"28","author":"Jordan","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bioorg.2024.107942_b0045","first-page":"211","article-title":"Resistance and Overcoming Resistance in Breast Cancer","volume":"12","author":"Luque-Bolivar","year":"2020","journal-title":"Breast Cancer (dove Med Press)"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107942_b0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/1566524023666230622151034","article-title":"Pharmacological Profile of Novel Anti-cancer Drugs Approved by USFDA in 2022: A Review","volume":"24","author":"Sangwan","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bioorg.2024.107942_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.719694","article-title":"Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids","volume":"12","author":"Tilaoui","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107942_b0060","first-page":"749","article-title":"Reactive oxygen species (ROS) are a crucial factor in the anticancer activity of Oliveria decumbens extract against the A431 human skin cell line","volume":"79","author":"Dinarvand","year":"2024","journal-title":"Archives of Razi Institute"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107942_b0065","article-title":"In Vitro Pharmacological Screening of Essential Oils from Baccharis parvidentata and Lippia origanoides Growing in Brazil, Molecules (Basel","volume":"27","author":"Perera","year":"2022","journal-title":"Switzerland)"},{"key":"10.1016\/j.bioorg.2024.107942_b0070","unstructured":"D. Shekarabi, s. safi, P. Mortazavi, Evaluation of apoptosis and caspase-3 activity in EL4 cell line lymphoma using Moringa oleifera plant extract, Archives of Razi Institute (2024) -."},{"key":"10.1016\/j.bioorg.2024.107942_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2019.01.005","article-title":"Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents","volume":"165","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106957","article-title":"Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery","volume":"142","author":"Hui","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nyas.13387","article-title":"Natural products to prevent drug resistance in cancer chemotherapy: a review","volume":"1401","author":"Yuan","year":"2017","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107942_b0090","doi-asserted-by":"crossref","unstructured":"L. Monzote, A.M. Scherbakov, R. Scull, P. Satyal, P. Cos, A.E. Shchekotikhin, L. Gille, W.N. Setzer, Essential Oil from Melaleuca leucadendra: Antimicrobial, Antikinetoplastid, Antiproliferative and Cytotoxic Assessment, Molecules (Basel, Switzerland) 25(23) (2020).","DOI":"10.3390\/molecules25235514"},{"key":"10.1016\/j.bioorg.2024.107942_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111691","article-title":"Indole: A privileged scaffold for the design of anti-cancer agents","volume":"183","author":"Wan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107942_b0100","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acs.jafc.0c06480","article-title":"Design, Synthesis, and Antifungal Evaluation of Cryptolepine Derivatives against Phytopathogenic Fungi","volume":"69","author":"Chen","year":"2021","journal-title":"J. Agric. Food. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107942_b0105","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2174\/138527211794785118","article-title":"Isolation, Biological Activities and Synthesis of Indoloquinoline Alkaloids: Cryptolepine, Isocryptolepine and Neocryptolepine","volume":"15","author":"Parvatkar","year":"2011","journal-title":"Curr. Org. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1570179412666150511224648","article-title":"Indoloquinolines: Possible Biogenesis from Common Indole Precursors and their Synthesis using Domino Strategies","volume":"13","author":"Parvatkar","year":"2015","journal-title":"Curr. Org. Synth."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2000-11106","article-title":"Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots","volume":"66","author":"Paulo","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2024.107942_b0120","first-page":"177","article-title":"Recent Advances in the Chemistry and Pharmacology of Cryptolepine","volume":"115","author":"Shnyder","year":"2021","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"32","key":"10.1016\/j.bioorg.2024.107942_b0125","doi-asserted-by":"crossref","first-page":"18978","DOI":"10.1039\/D0RA03096A","article-title":"Isolation and synthesis of cryptosanguinolentine (isocryptolepine), a naturally-occurring bioactive indoloquinoline alkaloid","volume":"10","author":"Thobokholt","year":"2020","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107942_b0130","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1021\/jm400694d","article-title":"Exquisite Selectivity for Human Toll-Like Receptor 8 in Substituted Furo[2,3-c]quinolines","volume":"56","author":"Kokatla","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0135","doi-asserted-by":"crossref","unstructured":"E.L. Larghi, A.B. Bracca, A.A. Arroyo Aguilar, D.A. Heredia, J.L. Pergomet, S.O. Simonetti, T.S. Kaufman, Neocryptolepine: A Promising Indoloisoquinoline Alkaloid with Interesting Biological Activity. Evaluation of the Drug and its Most Relevant Analogs, Curr. Top. Med. Chem. 15(17) (2015) 1683 - 1707, https:\/\/doi.org\/10.2174\/1568026615666150427113937.","DOI":"10.2174\/1568026615666150427113937"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jhet.5570330204","article-title":"Two new indoloquinoline alkaloids from cryptolepis sanguinolenta: Cryptosanguinolentine and cryptotackieine","volume":"33","author":"Sharaf","year":"1996","journal-title":"J. Heterocycl. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0031-9422(94)00925-J","article-title":"Isocryptolepine from Cryptolepis sanguinolenta","volume":"39","author":"Pousset","year":"1995","journal-title":"Phytochem."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107942_b0150","doi-asserted-by":"crossref","first-page":"e202300137","DOI":"10.1002\/ejoc.202300137","article-title":"Regiodivergent Synthesis of 11H-Indolo[3,2-c]quinolines and Neocryptolepine from a Common Starting Material","volume":"26","author":"H\u00e5heim","year":"2023","journal-title":"Eur. J. Org. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2024.107942_b0155","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1016\/j.bmc.2011.10.037","article-title":"Synthesis and antimalarial evaluation of novel isocryptolepine derivatives","volume":"19","author":"Whittell","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103266","article-title":"Design, synthesis and antifungal activity evaluation of isocryptolepine derivatives","volume":"92","author":"Li","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2015.02.047","article-title":"Synthesis of isocryptolepine analogues and their structure-activity relationship studies as antiplasmodial and antiproliferative agents","volume":"94","author":"Aroonkit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107942_b0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/np0496284","article-title":"Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound","volume":"68","author":"Van Miert","year":"2005","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107942_b0175","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bjp.2018.08.008","article-title":"Isocryptolepine, an indoloquinoline alkaloid from Cryptolepis sanguinolenta promotes LDL uptake in HepG2 cells","volume":"28","author":"Aggrey","year":"2018","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.bioorg.2024.107942_b0180","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1038\/srep09696","article-title":"KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines","volume":"5","author":"Lavrado","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107942_b0185","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.3390\/molecules191119021","article-title":"Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents","volume":"19","author":"Wang","year":"2014","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107942_b0190","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/molecules24112121","article-title":"Structural Modifications of Nature-Inspired Indoloquinolines: A Mini Review of Their Potential Antiproliferative Activity","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107942_b0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1134\/S1068162013010081","article-title":"Oligo(2'-O-Methylribonucleotides) and their derivatives: IV. Conjugates of oligo(2'-O-methylribonucleotides) with minor groove binders and intercalators: synthesis, properties and application","volume":"39","author":"Novopashina","year":"2013","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1515\/hc-2013-0034","article-title":"Indoloquinolines as DNA binding ligands","volume":"19","author":"Riechert-Krause","year":"2013","journal-title":"Heterocycl. Commun."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107942_b0205","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1021\/ic401573d","article-title":"Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution","volume":"52","author":"Primik","year":"2013","journal-title":"Inorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humupd\/6.3.212","article-title":"A pharmacological review of selective oestrogen receptor modulators","volume":"6","author":"Goldstein","year":"2000","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5487\/TR.2011.27.2.085","article-title":"The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells","volume":"27","author":"Chang","year":"2011","journal-title":"Toxicol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1759720X11422602","article-title":"Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis","volume":"4","author":"Komm","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107942_b0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/187152009788451833","article-title":"Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer","volume":"9","author":"Peng","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0230","first-page":"178","article-title":"Conjugated Estrogens\/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis","volume":"40","author":"Goldberg","year":"2015","journal-title":"P T"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107942_b0235","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bab.2150","article-title":"A comprehensive review on anticancer mechanism of bazedoxifene","volume":"69","author":"Zafar","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"64","key":"10.1016\/j.bioorg.2024.107942_b0245","doi-asserted-by":"crossref","first-page":"36980","DOI":"10.1039\/C8RA08155G","article-title":"A nitroalkane-based approach to one-pot three-component synthesis of isocryptolepine and its analogs with potent anti-cancer activities","volume":"8","author":"Aksenov","year":"2018","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0250","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/adsc.200700328","article-title":"Auto-Tandem Catalysis: Synthesis of Substituted 11H-Indolo[3,2-c]quinolines via Palladium-Catalyzed Intermolecular C-N and Intramolecular C-C Bond Formation","volume":"350","author":"Meyers","year":"2008","journal-title":"Adv. Synth. Catal."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107942_b0255","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1021\/cr040639b","article-title":"Synthesis and functionalization of indoles through palladium-catalyzed reactions","volume":"105","author":"Cacchi","year":"2005","journal-title":"Chem. Rev."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107942_b0260","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1021\/acs.orglett.9b01534","article-title":"Tunable Synthesis of Indolo[3,2-c]quinolines or 3-(2-Aminophenyl)quinolines via Aerobic\/Anaerobic Dimerization of 2-Alkynylanilines","volume":"21","author":"Jia","year":"2019","journal-title":"Org. Lett."},{"issue":"45","key":"10.1016\/j.bioorg.2024.107942_b0265","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1016\/j.tet.2013.08.019","article-title":"A concise synthesis of indoloquinoline skeletons applying two consecutive Pd-catalyzed reactions","volume":"69","author":"Bog\u00e1nyi","year":"2013","journal-title":"Tetrahedron"},{"issue":"28","key":"10.1016\/j.bioorg.2024.107942_b0270","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.tetlet.2011.05.049","article-title":"An efficient new route towards biologically active isocryptolepine and \u03b3-carboline derivatives using an intramolecular thermal electrocyclization strategy","volume":"52","author":"Hingane","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2024.107942_b0275","doi-asserted-by":"crossref","unstructured":"E. Schendera, L.-N. Unkel, P.P. Huyen Quyen, G. Salkewitz, F. Hoffmann, A. Villinger, M. Brasholz, Visible-Light-Mediated Aerobic Tandem Dehydrogenative Povarov\/Aromatization Reaction: Synthesis of Isocryptolepines, Chem. - Eur. J. 26(1) (2020) 269 - 274, https:\/\/doi.org\/10.1002\/chem.201903921.","DOI":"10.1002\/chem.201903921"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107942_b0280","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acs.orglett.5b03392","article-title":"Iodine-Mediated Intramolecular Dehydrogenative Coupling: Synthesis of N-Alkylindolo[3,2-c]- and -[2,3-c]quinoline Iodides","volume":"18","author":"Volvoikar","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2024.107942_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103142","article-title":"Novel steroidal 1,3,4-thiadiazines: Synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells","volume":"91","author":"Komendantova","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107942_b0290","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1021\/acsami.3c15853","article-title":"Riboflavin Crystals with Extremely High Water Solubility","volume":"16","author":"Krikunova","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"35","key":"10.1016\/j.bioorg.2024.107942_b0295","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1039\/D1OB01362A","article-title":"Light-driven photoswitching of quinazoline analogues of combretastatin A-4 as an effective approach for targeting skin cancer cells","volume":"19","author":"Scherbakov","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0300","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fphar.2017.00979","article-title":"Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells","volume":"8","author":"Scherbakov","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10637-023-01332-z","article-title":"Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells","volume":"41","author":"Scherbakov","year":"2023","journal-title":"Invest. New. Drugs"},{"issue":"23","key":"10.1016\/j.bioorg.2024.107942_b0310","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1021\/acs.orglett.9b03780","article-title":"Photoswitching off the Antiproliferative Activity of Combretastatin A-4 Analogues","volume":"21","author":"Yadykov","year":"2019","journal-title":"Org. Lett."},{"issue":"15","key":"10.1016\/j.bioorg.2024.107942_b0315","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1021\/acs.joc.8b00795","article-title":"Photochromic Indolyl Fulgimides as Chromo-pharmacophores Targeting Sirtuins","volume":"83","author":"Simeth","year":"2018","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2024.112032","article-title":"Structure and photophysical properties of furoquinoline aza-helicenes: Fluorescence enhancement by protonation","volume":"225","author":"Balakhonov","year":"2024","journal-title":"Dyes and Pigments"},{"issue":"21","key":"10.1016\/j.bioorg.2024.107942_b0325","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/adsc.202300833","article-title":"DABCO-Promoted Selective Photochemical C\u2212N Coupling: Access to Unsymmetrical Azahelicenes","volume":"365","author":"Balakhonov","year":"2023","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.bioorg.2024.107942_b0330","doi-asserted-by":"crossref","unstructured":"N.T. Abdel Ghani, A.M. Mansour, Novel palladium(II) and platinum(II) complexes with 1H-benzimidazol-2-ylmethyl-N-(4-bromo-phenyl)-amine: structural studies and anticancer activity, Eur. J. Med. Chem. 47(1) (2012) 399 - 411, https:\/\/doi.org\/10.1016\/j.ejmech.2011.11.008.","DOI":"10.1016\/j.ejmech.2011.11.008"},{"key":"10.1016\/j.bioorg.2024.107942_b0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2016.09.023","article-title":"Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities","volume":"125","author":"Akhtar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinorgbio.2014.07.009","article-title":"Effect of glucosamine conjugation to zinc(II) complexes of a bis-pyrazole ligand: syntheses, characterization and anticancer activity","volume":"140","author":"Bhattacharyya","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2024.107942_b0345","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2012.07.005","article-title":"Synthesis and antiproliferative evaluation of some new amidino-substituted bis-benzothiazolyl-pyridines and pyrazine","volume":"55","author":"Racane","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116364","article-title":"The role of the methoxy group in approved drugs","volume":"273","author":"Chiodi","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0355","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0360","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","article-title":"Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions","volume":"101","author":"Lipinski","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107942_b0365","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0370","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0375","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17460441.2020.1691995","article-title":"Is there enough focus on lipophilicity in drug discovery?","volume":"15","author":"Lobo","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"44","key":"10.1016\/j.bioorg.2024.107942_b0380","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1038\/s41388-018-0377-y","article-title":"GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer","volume":"37","author":"Hodgkinson","year":"2018","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107942_b0385","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/cmdc.202100554","article-title":"Synthesis of Isocryptolepine-Triazole Adducts and Evaluation of Their Cytotoxic Activity","volume":"16","author":"Rodphon","year":"2021","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0390","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/biom10010128","article-title":"The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms","volume":"10","author":"Banjara","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12964-024-01647-1","article-title":"Bcl-2 dependent modulation of Hippo pathway in cancer cells","volume":"22","author":"D'Aguanno","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bioorg.2024.107942_b0400","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2024.107942_b0405","doi-asserted-by":"crossref","unstructured":"M.A. Demeny, L. Virag, The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks, Cancers (Basel) 13(9) (2021) 2042, https:\/\/doi.org\/10.3390\/cancers13092042.","DOI":"10.3390\/cancers13092042"},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2024.107942_b0410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes. Dev."},{"key":"10.1016\/j.bioorg.2024.107942_b0415","doi-asserted-by":"crossref","unstructured":"A.H. Boulares, A.G. Yakovlev, V. Ivanova, B.A. Stoica, G. Wang, S. Iyer, M. Smulson, Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells, J. Biol. Chem. 274(33) (1999) 22932 - 22940, https:\/\/doi.org\/10.1074\/jbc.274.33.22932.","DOI":"10.1074\/jbc.274.33.22932"},{"issue":"21","key":"10.1016\/j.bioorg.2024.107942_b0420","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.3390\/ijms222111441","article-title":"PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols","volume":"22","author":"Maluchenko","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107942_b0425","first-page":"171","article-title":"PARP cleavage as a means of assessing apoptosis","volume":"88","author":"Mullen","year":"2004","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.bioorg.2024.107942_b0430","first-page":"103","volume":"6","author":"Scherbakov","year":"2023","journal-title":"Targeting Hormone-Resistant Breast Cancer Cells with Docetaxel: a Look inside the Resistance, Cancer Drug Resistance"},{"key":"10.1016\/j.bioorg.2024.107942_b0435","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107942_b0440","doi-asserted-by":"crossref","DOI":"10.3390\/polym12081798","article-title":"Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy","volume":"12","author":"Rochani","year":"2020","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0445","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107942_b0450","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1021\/acs.joc.5b02237","article-title":"General Photoinduced Sequential Electrocyclization\/[1,9]-Sigmatropic Rearrangement\/Ring-Opening Reaction of Diarylethenes","volume":"80","author":"Lvov","year":"2015","journal-title":"J. Org. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107942_b0455","first-page":"105","article-title":"Enhanced control of proliferation in telomerized cells","volume":"38","author":"Egorov","year":"2007","journal-title":"Ontogenez"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107942_b0460","first-page":"294","article-title":"Rational approach to the clinical protocol design for drug combinations: a review","volume":"41","author":"Chang","year":"2000","journal-title":"Acta Paediatr. Taiwan"},{"key":"10.1016\/j.bioorg.2024.107942_b0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","article-title":"The combination index (CI < 1) as the definition of synergism and of synergy claims","volume":"7","author":"Chou","year":"2018","journal-title":"Synergy"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107942_b0470","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1097-2765(03)00090-X","article-title":"Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling","volume":"11","author":"Reid","year":"2003","journal-title":"Mol. Cell"},{"issue":"18","key":"10.1016\/j.bioorg.2024.107942_b0475","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.3390\/ijms231810854","article-title":"Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K\/Akt\/mTOR Pathway","volume":"23","author":"Zapevalova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107942_b0480","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem."},{"key":"10.1016\/j.bioorg.2024.107942_b0485","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107942_b0490","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2024.107942_b0495","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107942_b0500","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107942_b0505","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon Parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res. Notes"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107942_b0510","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"51","key":"10.1016\/j.bioorg.2024.107942_b0515","doi-asserted-by":"crossref","first-page":"19824","DOI":"10.1021\/jp961710n","article-title":"Parametrized Models of Aqueous Free Energies of Solvation Based on Pairwise Descreening of Solute Atomic Charges from a Dielectric Medium","volume":"100","author":"Hawkins","year":"1996","journal-title":"J. Phys. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:28:55Z","timestamp":1738204135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":103,"alternative-id":["S0045206824008472"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107942","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photochemical Metal-Free synthesis and biological Assessment of isocryptolepine analogues targeting estrogen receptor Alpha in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107942"}}